About CANMAT           Help & Resources           Clinical Research          CME         
 
CME
interviews
 

PANIC DISORDER (WITH OR WITHOUT AGORAPHOBIA)

Panic disorder responds best to a combination of cognitive behavioural therapy (CBT) and antidepressant medication. CBT helps patients learn to deal with intense anxiety and feel more in control, while antidepressants help prevent panic attacks from occurring.

SSRIs (Selective Serotonin Reuptake Inhibitors)
The SSRIs are now considered the treatment of choice for panic and other types of anxiety disorders, producing both anxiolytic as well as antidepressant effects. Though generally better tolerated than older antidepressants, SSRIs may provoke hyperstimulatory reactions, which may be related to 5-HT2 postsynaptic sensitivity that is present until the antidepressant becomes effective. To avoid agitation, treatment should be initiated at lower doses than are used for depression, and increased to regular doses after one to two weeks. Adjunctive benzodiazepines may be used for two to four weeks.

Newer cyclic agents (nefazodone, venlafaxine) may also be effective in panic disorder, although experience with these agents is limited.

Older Antidepressants (TCAs/MAOIs)
These agents are useful (as are the SSRIs) in panic disorder with comorbid depression. The main drawback with both the TCAs and the MAOIs is lack of tolerance to their side effects. Up to 30% of patients feel jittery on these medications, so that symptoms of anxiety may seem to worsen initially. TCAs and MAOIs should also be used with caution in patients at risk for suicide. If either drug class is used, initial doses should be low and doses increased in small increments up to the therapeutic range.

Benzodiazepines
Alprazolam, clonazepam and lorazepam may be considered as alternatives to antidepressants, with approximately 50% of patients responding to these agents. Some clinicians favor alprazolam as their first choice because its onset of action is more immediate and it is not associated with any stimulatory reaction. Other clinicians favor clonazepam, which has a longer half-life than alprazolam, requires less frequent dosing, and is less problematic during withdrawal.

Panic attacks tend to respond to higher doses of alprazolam than are required to treat generalized anxiety disorder; however, patients usually respond within the first two weeks of treatment and anticipatory anxiety is similarly reduced.

Lorazepam is not considered to be as effective for panic disorder, however, it may be used sublingually in panic attack.

Once symptoms are controlled, the lowest effective dose should be used for maintenance therapy. Drawbacks to alprazolam include the need for multiple daily dosing and stopping treatment, which must be done over a period of several months, especially if high doses have been used.

Other Anxiolytics
The anxiolytic buspirone has no efficacy in the treatment of panic disorder (with or without agoraphobia) and should not be used.

Beta-Blockers
Comparisons between propranolol and benzodiazepines found the benzodiazepines to be superior in the alleviation of panic attacks. Beta-blockers may, however, offer added benefit in combination with a benzodiazepine.

Panic Disorder: Outcome
After 6 to 10 years of treatment for panic disorder, studies indicate that about 30% of patients are well; 40 to 50% are improved but symptomatic; and the remaining 20 to 30% are unimproved or worse.

Pharmacotherapy for Panic Disorder

Drug Class Drug

Starting Dose

*1/2 dose to start

Daily Maintenance Dose
Tricyclics

imipramine,

desipramine

10-25 mg/day 150-300 mg
MAOIs phenelzine 15 mg bid 45-90 mg
tranylcypromine 10 mg bid 30-70 mg
SSRIs fluoxetine 5-10 mg/day 20-80 mg
fluvoxamine 25 mg/day 50-300
paroxetine 10 mg/day 40-60 mg
sertaline 25 mg/day 50-200 mg
SNRIs venlafaxine 37.5 mg/day 75-300 mg
SRI/RBs nefazodone 50 mg bid 300-600 mg
Benzodiazepines alprazolam .25-.5 mg tid/qid 2-10 mg
clonazepam .25-.5 mg bid

adults: 1-9 mg

adolescents: .5-3 mg

lorazepam .5-1 mg bid 2-10 mg

 

 

Therapeutic Considerations in Panic Disorder

Drug Category Advantages Disadvantages
TCAs effective in comorbid depression slow onset of action
usually dosed once a day dose must be increased slowly to minimize side effects
side effects may decrease compliance
toxic in overdose
little effect on anticipatory anxiety
MAOIs as above as above
good antiphobic response dietary restrictions apply (moclobemide excepted)
possible drug interactions
SSRIs as above slow onset of action
dose must be increased slowly to minimize side effects
Benzodiazepines rapid onset of action multiple dosing often required
greater tolerance risk of dependency and possible withdrawal symptoms
better for anticipatory anxiety
low overdose potential

Adapted from Szeinbach, S, Summers KH. Improving pharmacotherapeutic outcomes in panic disorder. Drug Topics 1992;May 4:84-99.

 

Diagnosing Anxiety Disorders Menu

Treating Anxiety Disorders Menu

 



Over one million Canadians suffer from some form of depressive illness.